August 30, 2026
Curaleaf launched a hostile bid for Aurora Cannabis, the biggest single M&A story in today's market.
What happened
Curaleaf is pushing an unsolicited takeover of Aurora Cannabis. The evidence flags this as a hostile bid, meaning Aurora's board did not invite the offer. Meanwhile the broader market slipped: chipmaker Nvidia fell 4.6 percent, a bigger drop than on 92 percent of its days over the past three years.
Why it matters
In a takeover the buyer offers to purchase the target's shares, usually at a premium to lift the deal over the line. That premium tends to pull the target's stock up and weigh on the acquirer, which is footing the bill. A hostile approach means the fight goes public: the bidder appeals directly to shareholders while management resists, and other cannabis names can re-rate as investors guess who consolidates next.
The case against
Hostile bids often fail. Boards can reject the price, find a friendlier buyer, or run out the clock, so the initial pop can fade. Cannabis deals also face heavy regulatory scrutiny, which can stall or block a combination even when both sides agree.
What settles it
Whether Aurora's board formally accepts, rejects, or seeks a rival offer. That decision settles whether this becomes a real deal or a stalled overture.